Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30705688 | 0.81 | KDM4E (0.49) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL32662205 | 0.78 | GRIA1 (0.37) | KDM4EALDH1A1HPGDHSD17B10 | |
| Hydrochloric Acid SCHEMBL30705654 | 0.75 | — | — | |
| Hydrochloric Acid SCHEMBL30705545 | 0.75 | — | — | |
| SCHEMBL31376407 | 0.74 | KDM4E (0.46) | KDM4EALDH1A1HPGDHSD17B10HTT | |
| SCHEMBL20939569 | 0.70 | KDM4E (0.33) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL17678623 | 0.70 | KDM4E (0.64) | KDM4EALDH1A1HPGDHSD17B10HTT | |
| SCHEMBL24159176 | 0.69 | MAP2K1 (0.37) | KDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL20939530 | 0.68 | TNKS2 (0.38) | KDM4EALDH1A1HPGDHSD17B10HTT | |
| SCHEMBL32662518 | 0.66 | KDM4E (0.39) | KDM4EALDH1A1HPGDHSD17B10HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4539844-A2 | COMPOUNDS FOR TREATMENT OF A CORONAVIRUS INFECTION | Trawsfynydd Therapeutics, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-119604290-A | Compounds for the treatment of coronavirus infections | 特劳斯芬尼德治疗股份有限公司 | 2025-03-11 | — | — | CN | disclosed |
| WO-2023245166-A2 | COMPOUNDS FOR TREATMENT OF A CORONAVIRUS INFECTION | TRAWSFYNYDD THERAPEUTICS, INC. (US) | 2023-12-21 | — | — | WO | disclosed |